Acetic Acid → HCID 59556687, compound
Reaction equation
[CH:1]([C:3]1[CH:8]=[CH:7][C:6]([C:9]2[O:13][N:12]=[C:11]([C:14]3[CH:15]=[CH:16][C:17]([O:22][CH:23]([CH3:25])[CH3:24])=[C:18]([CH:21]=3)[C:19]#[N:20])[N:10]=2)=[CH:5][CH:4]=1)=O.[NH:26]1[CH2:29][CH:28]([C:30]([OH:32])=[O:31])[CH2:27]1.C(O)(=O)C.C([BH3-])#N>CO.ClCCCl>[C:19]([C:18]1[CH:21]=[C:14]([C:11]2[N:10]=[C:9]([C:6]3[CH:5]=[CH:4][C:3]([CH2:1][N:26]4[CH2:29][CH:28]([C:30]([OH:32])=[O:31])[CH2:27]4)=[CH:8][CH:7]=3)[O:13][N:12]=2)[CH:15]=[CH:16][C:17]=1[O:22][CH:23]([CH3:25])[CH3:24])#[N:20]Participants
Procedure
5-(5-(4-formylphenyl)-1,2,4-oxadiazol-3-yl)-2-isopropoxybenzonitrile (0.077 g, 0.231 mmol) and azetidine-3-carboxylic acid (0.028 g, 0.277 mmol) were combined in methanol (11.55 ml) and DCE (11.55 ml) in a sealed vial. Acetic acid (0.066 ml, 1.155 mmol) was added. The reaction mixture was stirred at ambient temperature for 2 hr. MP-cyanoborohydride (0.265 g, 0.570 mmol) was added and the reaction stirred for about 24 h. The solution was filtered, the solid was washed with methylene chloride and methanol, and the filtrate was concentrated to afford a white solid, which was recrystallized by methanol (5 mL) to give 1-(4-(3-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)benzyl)azetidine-3-carboxylic acid (0.025 g, 0.060 mmol, 25.9% yield) as white solid: LC/MS (Table 1, Method a) Rt=2.10 min.; MS m/z: 420.26 (M+H)+. 1H NMR (400 MHz, Solvent d-DMSO) ppm 8.35-8.28 (m, 2H), 8.17-8.11 (d, J=8.00 Hz, 2H), 7.56-7.50 (m, 8.69 Hz, 3H), 4.98-4.89 (m, 1H), 3.68 (s, 2H), 3.43 (s, 2H), 3.25-3.23 (m, 3H), 1.38 (d, J=6.03 Hz, 6H).
Workup
- stirringthe reaction stirred for about 24 h
- filtrationThe solution was filtered
- washthe solid was washed with methylene chloride and methanol
- concentrationthe filtrate was concentrated
- customto afford a white solid, which
- customwas recrystallized by methanol (5 mL)
Sources & evidence
- ORD record
- ord-33c2e45e138340bd9a911447d9704bcb
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07834039B2
Reaction notes
Loading…